Price
Target price
€0.76
€0.76
-2.290%
-0.0176
-2.290%
€6.95
02.07.24 / Tradegate
WKN: A1W77U / Symbol: KPTI / Name: Karyopharm / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Karyopharm Therapeutics Inc. Stock
A loss of -2.290% shows a downward development for Karyopharm Therapeutics Inc..
We see a rather positive sentiment for Karyopharm Therapeutics Inc. with 10 Buy predictions and 2 Sell predictions.
With a target price of 6 € there is potential for a 690.93% increase which would mean more than doubling the current price of 0.76 € for Karyopharm Therapeutics Inc..
Our community identified positive and negative aspects for Karyopharm Therapeutics Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Karyopharm Therapeutics Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Karyopharm Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karyopharm Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. | -2.290% | -25.990% | -14.611% | -56.750% | -8.953% | -91.484% | - |
Ardelyx Inc. | -31.220% | -12.398% | -22.159% | 58.645% | -14.913% | -26.597% | - |
Evolus Inc | 3.550% | 5.155% | -13.559% | 58.140% | 12.707% | -2.857% | - |
Krystal Biotech | -1.590% | -1.928% | 12.140% | 53.102% | 42.543% | - | - |
Comments
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at HC Wainwright from $8.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KPTI provided by MarketBeat
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Show more
Ratings data for KPTI provided by MarketBeat
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Show more
Ratings data for KPTI provided by MarketBeat
News
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ: KPTI)Q1 2024 Earnings CallMay 08, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ: KPTI)Q4 2023 Earnings CallFeb 29, 2024, 8:00 a.m. ET
Operator
Source Fool.com